Cite
APA Citation
Zangardi, M. L., Spring, L. M., Blouin, G. C., & Bardia, A. (2017). ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer. Expert review of clinical pharmacology, 10(11), 1169–1176. http://access.bl.uk/ark:/81055/vdc_100052529849.0x000014